androgenic alopecia
Conditions
Interventions
Sponsors
Shanghai Tongji Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. The typical clinical manifestations were in accordance with the diagnosis of AGA, and the degree of hair loss was in accordance with the BASP classification of androgenic hair loss; 2. In general, patients with good condition (no previous heart, systemic or scalp diseases) have not used any drugs that may affect hair growth (antihypertensive drugs, hormones, cytotoxic drugs, anti androgen drugs, etc.) within the first 3 months of the study; 3. Patients who agree to participate in observation and follow-up, are willing to receive follow-up, and can cooperate closely in the whole process.
Exclusion criteria
Exclusion criteria: 1. Finasteride was taken orally 18 months before the start of the experiment; 2. Use local or systemic drugs that affect hair growth within 12 months; 3. History of hair transplantation; 4. Systemic or scalp diseases that may affect hair growth.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| P.Suchonwanit 7-point rating scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Dermatology Life Quality Index;Evaluation of hair regeneration rate;Severity of Alopecia Tool, SALT;Measuring the thickness and density of hair with a dermatoscope;Using 4-point scale to evaluate patients' subjective satisfaction; | — |
Countries
China
Contacts
Public ContactHuang Xin
Shanghai Tongji Hospital
Outcome results
None listed